For Hematopoietic Stem Cell Transplant Support and Prevention of Graft-Versus-Host Disease Read more…
Funding supports advancement for treatment of Neurological and Cardiovascular Conditions and Advanced Manufacturing Platform Read more…
Setting the course for FY12 Read more…
ATHX receives Funding to advance Clinical Development of MultiStem® Read more…
P1 Study of MultiStem(R) targeting risk for Graft Versus Host Disease Read more…
ATHX reported that results from a P1 trial of its stem cell therapy Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.